Onderzoeker
Bert Schepens
- Disciplines:Biofysica, Moleculaire en celbiologie, Laboratoriumgeneeskunde, Microbiologie, Systeembiologie, Plantenbiologie, Medicinale en biomoleculaire chemie
Affiliaties
- Vakgroep Biochemie en Microbiologie (Departement)
Lid
Vanaf1 okt 2019 → Heden - Vakgroep Biomedische Moleculaire Biologie (Departement)
Lid
Vanaf1 feb 2001 → 30 sep 2019
Publicaties
1 - 6 van 6
- Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice(2019)
Auteurs: Patrick Tjok Joe, Ioanna Christopoulou, Lien Van Hoecke, Bert Schepens, Tine Ysenbaert, Carlo Heirman, Kris Thielemans, Xavier Saelens, Joeri Aerts
- Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface(2019)
Auteurs: Annasaheb Kolpe, Maria Arista-Romero, Bert Schepens, Silvia Pujals, Xavier Saelens, Lorenzo Albertazzi
- Respiratory syncytial virus nonstructural proteins 1 and 2 : exceptional disrupters of innate immune responses(2019)
Auteurs: Koen Sedeyn, Bert Schepens, Xavier Saelens
- Selective engagement of FcγRIV by a M2e-specific single domain antibody construct protects against influenza A virus infection(2019)
Auteurs: Dorien De Vlieger, Katja Hoffmann, Inge Van Molle, Wim Nerinckx, Lien Van Hoecke, Marlies Ballegeer, Sarah Creytens, Han Remaut, Hartmut Hengel, Bert Schepens, et al.
- Phosphoproteomics to characterize host response during influenza A virus infection of human macrophages(2016)
Auteurs: Sandra Söderholm, Denis E Kainov, Tiina Öhman, Oxana V Denisova, Bert Schepens, Evgeny Kulesskiy, Susumu Y Imanishi, Garry Corthals, Petteri Hintsanen, Tero Aittokallio, et al.
Pagina's: 3203 - 3219 - The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice(2015)
Auteurs: Maria Anastasina, Bert Schepens, Sandra Söderholm, Tuula A Nyman, Sampsa Matikainen, Kalle Saksela, Xavier Saelens, Denis E Kainov
Pagina's: 2086 - 2091
Patenten
1 - 3 van 3
- CORONA VIRUS BINDERS (Inventor)
- SINGLE DOMAIN ANTIBODY AGAINST RSV F PROTEIN (Inventor)
- RESPIRATORY SYNCYTICAL VIRUS VACCINE (Inventor)